ChromaDex Announces the Availability of an Expanded 2011 Phytochemical Catalog
IRVINE, Calif., Oct. 12 /PRNewswire/ — ChromaDex Corporation (OTC Bulletin Board: CDXC), a leader in phytochemical reference standards and related contract analysis and research services, today released a 2011 phytochemical product catalog designed to provide the dietary supplement industry with the analytical and research tools needed to meet the requirements of the Food and Drug Administration’s (FDA) Good Manufacturing Practice Regulations.
ChromaDex has added over 1,000 new products to its portfolio, which brings the total found in the new catalog to over 4,000 phytochemical and botanical reference materials. A few of the new items include an all-in-one JECFA Stevia test kit, 200 new botanical reference materials and an extensive natural product extract library for use in high-throughput screening.
Additionally, the enhanced Product Selection Guide provides a fast, easy way to locate the relevant standards for almost any botanical. The catalog also outlines the comprehensive testing and research capabilities available from ChromaDex.
“The product selection guide featured in the new catalog, which has now become a resource for the industry, is organized by botanical and truly represents both the depth and breadth of the ChromaDex product line,” said Frank Jaksch, cofounder and CEO of ChromaDex. “ChromaDex has over a decade of phytochemical experience which is highly reflected in this expanded 500 page catalog.”
The ChromaDex(TM) 2011 Phytochemical catalog will be distributed worldwide and is available online at www.chromadex.com or by contacting a ChromaDex sales representative at
949-419-0288 or by e-mail at firstname.lastname@example.org.
ChromaDex is a leader in the development of phytochemical and botanical reference standards and the creation of associated intellectual property. ChromaDex is committed to sustainable “green chemistry” and provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the novel ingredients, analytical tools and services to meet product regulatory, quality, efficacy and safety standards. The Company recently introduced its pTeroPure line of high quality dietary supplement ingredients. ChromaDex initiated a clinical study of its new product, pTeroPure(TM) pterostilbene (http://www.pteropure.com/). The company has worldwide exclusive patent rights related to pterostilbene. For more information, visit http://www.chromadex.com/ or follow ChromaDex on Twitter @ChromaDex.
Investor Inquiries Liviakis Financial Communications, Inc. John M. Liviakis, President 415-389-4670 John@Liviakis.com ChromaDex Contact Jenny Robles Administrative Assistant to the CEO 10005 Muirlands Blvd, Suite G, Irvine, CA 92618 949-419-0288 email@example.com Media Contact Megan Lavine Canale Communications 3033 5th Ave., Suite 400, San Diego, CA 92103 619-849-5388 firstname.lastname@example.org
SOURCE ChromaDex Corporation